XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Capital Surplus
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2020 $ 2,605,758 $ 1,651 $ 1,520,617 $ 1,039,370 $ 44,120
Comprehensive income:          
Net income 319,021     319,021  
Other comprehensive loss (33,658)       (33,658)
Net issuance of shares of common stock from exercise of stock options 2,374 2 2,372    
Repurchase of shares of common stock (44,480) (18) (44,462)    
Share-based compensation net issuance of shares of restricted common stock 8,848 2 8,846    
Cash dividends - Common Stock (92,142)     (92,142)  
Ending balance at Dec. 31, 2021 2,765,721 1,637 1,487,373 1,266,249 10,462
Comprehensive income:          
Net income 305,262     305,262  
Other comprehensive loss (315,920)       (315,920)
Net issuance of shares of common stock from exercise of stock options 156 2 154    
Issuance of common stock 961,290 424 960,866    
Repurchase of shares of common stock (70,856) (31) (70,825)    
Share-based compensation net issuance of shares of restricted common stock 9,133 2 9,131    
Cash dividends - Common Stock (128,424)     (128,424)  
Ending balance at Dec. 31, 2022 3,526,362 2,034 2,386,699 1,443,087 (305,458)
Comprehensive income:          
Net income 392,929     392,929  
Other comprehensive loss 56,383       56,383
Net issuance of shares of common stock from exercise of stock options 802 1 801    
Repurchase of shares of common stock (48,341) (22) (48,319)    
Share-based compensation net issuance of shares of restricted common stock 9,274 2 9,272    
Excise tax expense from repurchase of common stock (430)   (430)    
Cash dividends - Common Stock (145,904)     (145,904)  
Ending balance at Dec. 31, 2023 $ 3,791,075 $ 2,015 $ 2,348,023 $ 1,690,112 $ (249,075)